These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15309494)

  • 1. Clinical use of gadolinium chelates for non-MRI applications.
    Karcaaltincaba M; Basaran C; Akata D
    Eur Radiol; 2005 Jan; 15(1):191; author reply 192. PubMed ID: 15309494
    [No Abstract]   [Full Text] [Related]  

  • 2. Actual clinical use of gadolinium-chelates for non-MRI applications.
    Strunk HM; Schild H
    Eur Radiol; 2004 Jun; 14(6):1055-62. PubMed ID: 14872279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of gadolinium chelates as an alternative radiographic contrast agent for use with flat panel detector angiography.
    Hui FK; Tong FC; Dion JE
    J Neurointerv Surg; 2011 Mar; 3(1):95-7. PubMed ID: 21990800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold nanomaterials functionalised with gadolinium chelates and their application in multimodal imaging and therapy.
    Perry HL; Botnar RM; Wilton-Ely JDET
    Chem Commun (Camb); 2020 Apr; 56(29):4037-4046. PubMed ID: 32236263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamic stability and kinetic inertness of a Gd-DTPA bisamide complex grafted onto gold nanoparticles.
    Mogilireddy V; Déchamps-Olivier I; Alric C; Laurent G; Laurent S; Vander Elst L; Muller R; Bazzi R; Roux S; Tillement O; Chuburu F
    Contrast Media Mol Imaging; 2015; 10(3):179-87. PubMed ID: 25130910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: high-dose intravenous gadolinium for renal computed tomographic angiography.
    Eggebrecht H; Quick HH; Barkhausen J; Kribben A; Erbel R
    J Vasc Interv Radiol; 2005 Feb; 16(2 Pt 1):297; author reply 297-8. PubMed ID: 15713935
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gadolinium chelating agents for arteriography and CT x-ray].
    Trillaud H
    J Radiol; 2002 Nov; 83(11):1715-6. PubMed ID: 12469008
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of gadolinium chelates for X-ray digital subtraction angiography.
    Wagner HJ; Kalinowski M; Klose KJ; Alfke H
    Invest Radiol; 2001 May; 36(5):257-65. PubMed ID: 11323513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadolinium-enhanced MDCT angiography of the abdomen: feasibility and limitations.
    Chicoskie C; Tello R
    AJR Am J Roentgenol; 2005 Jun; 184(6):1821-8. PubMed ID: 15908537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted delivery of gold nanoparticle contrast agents for reporting gene detection by magnetic resonance imaging.
    Vistain LF; Rotz MW; Rathore R; Preslar AT; Meade TJ
    Chem Commun (Camb); 2016 Jan; 52(1):160-3. PubMed ID: 26505558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats.
    Tweedle MF; Wedeking P; Kumar K
    Invest Radiol; 1995 Jun; 30(6):372-80. PubMed ID: 7490190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Black" contrast effect during magnetic resonance arthrography attributable to inadvertent administration of excessive gadolinium chelates.
    Aydingoz U; Kerimoglu U; Canyigit M
    J Comput Assist Tomogr; 2005; 29(3):333-5. PubMed ID: 15891502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography.
    Spinosa DJ; Kaufmann JA; Hartwell GD
    Radiology; 2002 May; 223(2):319-25; discussion 326-7. PubMed ID: 11997531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography].
    Engelbrecht V; Koch JA; Rassek M; Mödder U
    Rofo; 1996 Jul; 165(1):24-8. PubMed ID: 8765359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: prospective evaluation in 60 patients.
    Remy-Jardin M; Bahepar J; Lafitte JJ; Dequiedt P; Ertzbischoff O; Bruzzi J; Delannoy-Deken V; Duhamel A; Remy J
    Radiology; 2006 Mar; 238(3):1022-35. PubMed ID: 16505397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of approved MR contrast media for intravenous injection.
    Runge VM
    J Magn Reson Imaging; 2000 Aug; 12(2):205-13. PubMed ID: 10931582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA].
    Claussen C; Kornmesser W; Laniado M; Kaminsky S; Hamm B; Felix R
    Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia?
    Nyman U; Elmståhl B; Leander P; Nilsson M; Golman K; Almén T
    Radiology; 2002 May; 223(2):311-8; discussion 328-9. PubMed ID: 11997530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrocyclic Versus Linear Gadolinium Chelates.
    Runge VM
    Invest Radiol; 2015 Dec; 50(12):811. PubMed ID: 26523911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.